Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic significance of high circulating sHLA-G in ovarian carcinoma.

HLA - 1 Oct 2021

Babay Wafa, Boujelbene Nadia, Ben Yahia Hamza, Bortolotti Daria, Zemni Ines, Ouzari Hadda-Imene, Chelbi Hanene, Mezlini Amel, Rizzo Roberta, Zidi Inès

Abstract excerpt

HLA-G is a non-classical major histocompatibility complex class Ib molecule. Its expression has been described in various cancer types, including ovarian cancer. HLA-G molecule has been implicated in immune escape and in progression of ovarian tumor cells. Our goal was to assess if total soluble (s)HLA-G molecules or HLA-G5 and sHLA-G1 isoforms could be considered as circulating ovarian tumor biomarkers, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histocompatibility Antigens Class I

Share to HLA Antigens

Share to HLA-G Antigens

Share to Neoplasm Recurrence, Local

Share to Ovarian Neoplasms

Share to Prognosis

Source

Identifiers

PMID: 34272932
DOI: 10.1111/tan.14374

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic significance of high circulating sHLA-G in ovarian carcinoma.PMID 34272932Read ↗

Plasma soluble HLA‐G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancerSemantic proximity Read ↗

HLA-G 3’UTR polymorphism diplotypes and soluble HLA-G plasma levels impact cervical cancer susceptibility and prognosisSemantic proximity Read ↗

Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancerSemantic proximity Read ↗

HLA-G as a new tumor biomarker: detection of soluble isoforms of HLA-G in the serum and saliva of patients with colorectal cancerSemantic proximity Read ↗

Clinical and biological significance of HLA-G expression in ovarian cancerSemantic proximity Read ↗

HLA-G 3′ untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancerSemantic proximity Read ↗

Some Basic Aspects of HLA-G BiologySemantic proximity Read ↗

Heterogeneity of HLA-G Expression in Cancers: Facing the ChallengesSemantic proximity Read ↗

Association of HLA-G*01:01:02:01/G*01:04:01 polymorphism with gastric adenocarcinoma.Semantic proximity Read ↗

The correlation between soluble human leukocyte antigen (sHLA-G) levels and +3010 polymorphism.Semantic proximity Read ↗

Implication of Soluble HLA-G and HLA-G +3142G/C Polymorphism in Breast Cancer Patients Receiving Adjuvant Therapy in Tanzania.Semantic proximity Read ↗

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.